Log In
BCIQ
Print this Print this
 

G1T38

  Manage Alerts
Collapse Summary General Information
Company G1 Therapeutics Inc.
DescriptionOral cyclin dependent kinase 4 (CDK4) and CDK6 inhibitor
Molecular Target Cyclin dependent kinase 4 (CDK4) ; Cyclin dependent kinase 6 (CDK6)
Mechanism of ActionCyclin dependent kinase 4 (CDK4) inhibitor; Cyclin dependent kinase 6 (CDK6) inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationSolid tumors
Indication DetailsTreat CDK4/CDK6-dependent tumors
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today